Palvella Therapeutics PVLA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$7.26M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 14.92% to 18.06% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Westfield Capital Management Company, L.P. | Mutual Fund | 2026/Q3 | +396,045 | 2.7% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +232,082 | 1.8% |
| William Blair Investment Management, LLC | Mutual Fund | 2026/Q3 | +195,070 | 1.3% |
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +141,033 | 7.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +71,334 | 6.8% |
| Nan Fung Trinity (HK) Limited | VC/PE Fund | 2026/Q3 | +52,630 | 0.4% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +46,995 | 0.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +45,933 | 1.3% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +35,432 | 2.1% |
| William Blair Investment Management, LLC | Mutual Fund | 2026/Q3 | +68,710 | 0.5% |
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +320,008 | 6.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +236,304 | 4.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +231,504 | 6.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +194,173 | 4.5% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +157,760 | 2.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 10 Nov 2026 | Jeffrey Martini | Chief Scientific Officer | Derivative Exercise and Sale | -12,500 | $172.12 | – |
| 9 Nov 2026 | Jeffrey Martini | Chief Scientific Officer | Intent to Sell (Form 144) | -50,000 | $174.08 | – |
| 20 Oct 2026 | Kathleen Goin | Chief Operating Officer | Derivative Exercise and Sale | -4,313 | $126.19 | – |
| 13 Oct 2026 | George Jenkins | Independent Chairperson | Automatic Disposition | -27,500 | $136.44 | 132,616 |
| 12 Oct 2026 | George Jenkins | Independent Chairperson | Intent to Sell (Form 144) | -27,500 | $134.38 | – |
| 15 Sep 2026 | Kathleen Goin | Chief Operating Officer | Derivative Exercise and Sale | -4,302 | $153.24 | – |
| 14 Sep 2026 | George Jenkins | Independent Chairperson | Automatic Disposition | -27,500 | $153.10 | 160,116 |
| 10 Sep 2026 | George Jenkins | Independent Chairperson | Intent to Sell (Form 144) | -27,500 | $150.39 | – |
| 1 Sep 2026 | Christopher Kiritsy | Independent Director | Derivative Exercise and Sale | -313 | $157.00 | 250 |
| 18 Aug 2026 | Kathleen Goin | Chief Operating Officer | Derivative Exercise and Sale | -4,302 | $156.77 | – |
| 14 Jul 2026 | Kathleen Goin | Chief Operating Officer | Derivative Exercise and Sale | -4,302 | $150.25 | – |
| 28 Jun 2026 | Matthew Pauls | Director | Other Derivative Acquisition | +6,000 | $154.84 | 6,000 |
| 16 Jun 2026 | Kathleen Goin | Chief Operating Officer | Derivative Exercise and Sale | -4,302 | $112.23 | – |
| 11 Jun 2026 | Matthew Korenberg | CFO, Corporate Secretary & Treasurer | Derivative Exercise and Retained | +1,000 | $13.60 | 1,000 |
| 9 Jun 2026 | George Jenkins | Independent Chairperson | Other Derivative Acquisition | +3,000 | $102.19 | 3,000 |
| 9 Jun 2026 | Elaine Heron | Independent Director | Other Derivative Acquisition | +3,000 | $102.19 | 3,000 |
| 9 Jun 2026 | Todd Davis | Independent Director | Other Derivative Acquisition | +3,000 | $102.19 | 3,000 |
| 9 Jun 2026 | Christopher Kiritsy | Independent Director | Other Derivative Acquisition | +3,000 | $102.19 | 3,000 |
| 9 Jun 2026 | Tadd Wessel | Independent Director | Other Derivative Acquisition | +3,000 | $102.19 | 3,000 |
| 9 Jun 2026 | John Doux | Independent Director | Other Derivative Acquisition | +3,000 | $102.19 | 3,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,601,661 | 18.1% | 11.5 |
| 15 Oct 2026 | 2,407,482 | 16.7% | 9.8 |
| 30 Sep 2026 | 2,524,140 | 17.5% | 10.7 |
| 15 Sep 2026 | 2,325,699 | 16.1% | 12.8 |
| 31 Aug 2026 | 2,291,288 | 15.9% | 11.1 |
| 14 Aug 2026 | 2,149,544 | 14.9% | 12.8 |
No comments yet — be the first to weigh in on PVLA.
Sign in to join the discussion.